Pfizer says phase 3 data buoys Litfulo as a vitiligo treatment

Pfizer's Phase 3 data for Litfulo as a treatment for alopecia areata is positive, which could act as a positive catalyst for the stock price.

AI CATALYST SCORE65 / 100Score computed by Sentinel V12

REFERENCE PRICENot measuredReference entry price at analysis time

ANALYSIS HISTORY

PFE Analysis History (Last 30 Days)

Diagnosed At	Ticker	AI Score	Tier
2026-10-02 16:13:29	PFE	65	Mid	View Report →
2026-10-01 18:04:03	PFE	40	Row	View Report →
2026-10-01 17:15:17	PFE	40	Row	View Report →

RELATED REPORTS

Diagnosed At	Ticker	AI Score	Tier
2026-10-02 21:53:56	CBLL	30	Row	View Report →
2026-10-02 21:48:45	NVO	40	Row	View Report →
2026-10-02 21:48:21	IRTC	40	Row	View Report →
2026-10-02 20:31:36	LLY	65	Mid	View Report →
2026-10-02 20:25:29	ITGR	30	Row	View Report →
2026-10-02 15:18:46	LLY	75	Mid	View Report →
2026-10-02 11:58:39	THC	55	Mid	View Report →
2026-10-02 11:21:34	NVS	60	Mid	View Report →
2026-10-02 07:17:42	NVS	65	Mid	View Report →
2026-10-02 06:47:26	SMMT	75	S-Class	View Report →
2026-10-02 00:40:43	MRNA	62	Mid	View Report →
2026-10-01 15:55:48	REGN	80	Mid	View Report →
2026-10-01 15:27:33	ABBV	65	Mid	View Report →
2026-10-01 15:12:16	MCK	55	Mid	View Report →
2026-10-01 14:27:18	HUM	45	Mid	View Report →
2026-10-01 14:07:39	SINT	78	S-Class	View Report →
2026-10-01 11:42:00	LLY	78	Mid	View Report →
2026-10-01 06:41:41	REGN	70	Mid	View Report →
2026-09-30 23:45:53	TRUP	15	Row	View Report →
2026-09-30 20:39:23	CVS	50	Mid	View Report →
2026-09-30 14:48:10	LLY	70	Mid	View Report →
2026-09-30 14:19:45	LLY	78	Mid	View Report →
2026-09-30 13:34:55	MRK	65	Mid	View Report →
2026-09-30 12:43:08	ABT	65	Mid	View Report →
2026-09-30 11:26:18	MRNA	45	Mid	View Report →
2026-09-30 11:16:06	MRNA	40	Row	View Report →
2026-09-30 10:15:57	ABBV	75	Mid	View Report →
2026-09-30 09:50:51	NVO	78	Mid	View Report →
2026-09-30 06:29:47	ABBV	70	Mid	View Report →
2026-09-29 17:35:33	AZN	60	Mid	View Report →